Chinese Yuan: Neutral within 6.7620–6.7980 band versus US Dollar – UOB
UOB’s Quek Ser Leang and Lee Sue Ann observe that USD/CNH edged higher toward 6.79 but upward momentum remains limited. For the day, they expect consolidation in a 6.7800–6.7950 range. On a 1–3 week view, the pair is described as neutral, likely to trade between 6.7620 and 6.7980, while the broader 1–3 month bias still points to a gradual grind lower.
Range trading dominates Dollar Yuan
"24-HOUR VIEW: After our expectation for USD to “test 6.7850” did not turn out last Thursday, we indicated on Friday that “although upward momentum has not increased significantly, there is still a chance for USD to test 6.7850.” We added, “the next resistance at 6.7980 is unlikely to come under threat.” USD subsequently rose and broke above 6.7850, reaching a high of 6.7919. Despite the advance, upward momentum has not increased much. Today, instead of continuing to advance, USD is more likely to trade in a higher range of 6.7800/6.7950."
"1-3 WEEKS VIEW: Last Thursday (04 Jun, spot at 6.7750), we highlighted that the earlier “downward momentum has faded, and we are neutral on USD now,” and we expected USD “to trade between 6.7620 and 6.7980 for the time being.” On Friday, USD rose to a high of 6.7919. The increase in upward momentum is not sufficient to indicate a continued rise. In other words, we continue to hold the same view for now."
(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Potentially the Biggest Deal in the Biopharmaceutical Industry in Recent Years! Sanofi (SNY.US) Plans Major Acquisition; Insmed (INSM.US) Stock Surges Over 20%!
According to informed sources, Sanofi is evaluating the possibility of acquiring the American pharmaceutical company Insmed. With the appointment of a new CEO, the French pharmaceutical company is actively seeking its next blockbuster drug.
The largest IPO in history surged and then pulled back on its first day; S&P and Nvidia fell for six consecutive sessions; Dow Jones dropped below 50,000 points; gold fell another 3%.
The Philadelphia Semiconductor Index fell by 2.4%, with AMD plummeting 7.7% due to short selling and Nvidia dropping 3.3% to a 52-week low. Oracle declined 3%, hitting a one-year low during intraday trading. CoreWeave fell 6.1%. The 10-year U.S. Treasury yield decreased by 1.5 basis points. The U.S. Dollar Index rose 0.2%, reaching an 18-month high. Offshore RMB dropped to a one-month low, touching the 6.70 level. WTI crude oil rose 1.1%. Gold hit its lowest level since last September. Silver declined 3%. Bitcoin fell 2%, returning to its July lows.
Strategy shares fall 4.6% to $86 after Bitcoin dips below $62,000
The likelihood of a 50 basis point rate hike by the Federal Reserve in December is rising; Goolsbee says all options are on the table and warns of persistently high inflation.
Chicago Federal Reserve President Goolsbee said on Thursday that, given U.S. inflation has remained at a concerningly high level for several consecutive months, he will consider all policy options at the Federal Reserve's December monetary policy meeting and has not ruled out the possibility of a one-time 50 basis point interest rate hike.
